325 related articles for article (PubMed ID: 30696688)
1. The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-κB signaling and STING's dual role during MCMV infection.
Stempel M; Chan B; Juranić Lisnić V; Krmpotić A; Hartung J; Paludan SR; Füllbrunn N; Lemmermann NA; Brinkmann MM
EMBO J; 2019 Mar; 38(5):. PubMed ID: 30696688
[TBL] [Abstract][Full Text] [Related]
2. The murine cytomegalovirus M35 protein antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-κB mediated transcription.
Chan B; Gonçalves Magalhães V; Lemmermann NAW; Juranić Lisnić V; Stempel M; Bussey KA; Reimer E; Podlech J; Lienenklaus S; Reddehase MJ; Jonjić S; Brinkmann MM
PLoS Pathog; 2017 May; 13(5):e1006382. PubMed ID: 28542326
[TBL] [Abstract][Full Text] [Related]
3. STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist.
Le-Trilling VTK; Wohlgemuth K; Rückborn MU; Jagnjic A; Maaßen F; Timmer L; Katschinski B; Trilling M
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743368
[TBL] [Abstract][Full Text] [Related]
4. The Cytomegalovirus M35 Protein Directly Binds to the Interferon-β Enhancer and Modulates Transcription of
Schwanke H; Gonçalves Magalhães V; Schmelz S; Wyler E; Hennig T; Günther T; Grundhoff A; Dölken L; Landthaler M; van Ham M; Jänsch L; Büssow K; van den Heuvel J; Blankenfeldt W; Friedel CC; Erhard F; Brinkmann MM
J Virol; 2023 Jun; 97(6):e0040023. PubMed ID: 37289084
[TBL] [Abstract][Full Text] [Related]
5. Marek's Disease Virus RLORF4 Inhibits Type I Interferon Production by Antagonizing NF-κB Activation.
Liu Y; Gao L; Xu Z; Luo D; Zhang Y; Gao Y; Liu C; Zhang Y; Qi X; Cui H; Li K; Wang X
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243133
[TBL] [Abstract][Full Text] [Related]
6. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
7. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections.
Yum S; Li M; Fang Y; Chen ZJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33785602
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted evasion of the interferon response by cytomegalovirus.
Marshall EE; Geballe AP
J Interferon Cytokine Res; 2009 Sep; 29(9):609-19. PubMed ID: 19708810
[TBL] [Abstract][Full Text] [Related]
9. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
[TBL] [Abstract][Full Text] [Related]
10. Modular Architecture of the STING C-Terminal Tail Allows Interferon and NF-κB Signaling Adaptation.
de Oliveira Mann CC; Orzalli MH; King DS; Kagan JC; Lee ASY; Kranzusch PJ
Cell Rep; 2019 Apr; 27(4):1165-1175.e5. PubMed ID: 31018131
[TBL] [Abstract][Full Text] [Related]
11. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
[TBL] [Abstract][Full Text] [Related]
12. cGAS-STING Signaling Regulates Initial Innate Control of Cytomegalovirus Infection.
Lio CW; McDonald B; Takahashi M; Dhanwani R; Sharma N; Huang J; Pham E; Benedict CA; Sharma S
J Virol; 2016 Sep; 90(17):7789-97. PubMed ID: 27334590
[TBL] [Abstract][Full Text] [Related]
13. Murine cytomegalovirus virion-associated protein M45 mediates rapid NF-κB activation after infection.
Krause E; de Graaf M; Fliss PM; Dölken L; Brune W
J Virol; 2014 Sep; 88(17):9963-75. PubMed ID: 24942588
[TBL] [Abstract][Full Text] [Related]
14. STING induces early IFN-β in the liver and constrains myeloid cell-mediated dissemination of murine cytomegalovirus.
Tegtmeyer PK; Spanier J; Borst K; Becker J; Riedl A; Hirche C; Ghita L; Skerra J; Baumann K; Lienenklaus S; Doering M; Ruzsics Z; Kalinke U
Nat Commun; 2019 Jun; 10(1):2830. PubMed ID: 31249303
[TBL] [Abstract][Full Text] [Related]
15. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.
Amsler L; Verweij M; DeFilippis VR
J Mol Biol; 2013 Dec; 425(24):4857-71. PubMed ID: 24013068
[TBL] [Abstract][Full Text] [Related]
16. Host-Adapted Gene Families Involved in Murine Cytomegalovirus Immune Evasion.
Becker S; Fink A; Podlech J; Reddehase MJ; Lemmermann NA
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062332
[TBL] [Abstract][Full Text] [Related]
17.
Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
[TBL] [Abstract][Full Text] [Related]
18. UL36 Rescues Apoptosis Inhibition and
Chaudhry MZ; Kasmapour B; Plaza-Sirvent C; Bajagic M; Casalegno Garduño R; Borkner L; Lenac Roviš T; Scrima A; Jonjic S; Schmitz I; Cicin-Sain L
Front Cell Infect Microbiol; 2017; 7():312. PubMed ID: 28770171
[TBL] [Abstract][Full Text] [Related]
19. microRNA-221 restricts human cytomegalovirus replication via promoting type I IFN production by targeting SOCS1/NF-κB pathway.
Yan B; Ma H; Jiang S; Shi J; Yang Z; Zhu W; Kong C; Chen L; Yan H; Ma C
Cell Cycle; 2019 Nov; 18(22):3072-3084. PubMed ID: 31550968
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses.
Choi HJ; Park A; Kang S; Lee E; Lee TA; Ra EA; Lee J; Lee S; Park B
Nat Commun; 2018 Jan; 9(1):125. PubMed ID: 29317664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
